263 related articles for article (PubMed ID: 28121641)
1. Suboptimal Compliance With National Comprehensive Cancer Network Melanoma Guidelines: Who Is at Risk?
Blakely AM; Comissiong DS; Vezeridis MP; Miner TJ
Am J Clin Oncol; 2018 Aug; 41(8):754-759. PubMed ID: 28121641
[TBL] [Abstract][Full Text] [Related]
2. Hospital-Based Study of Compliance with NCCN Guidelines and Predictive Factors of Sentinel Lymph Node Biopsy in the Setting of Thin Melanoma Using the National Cancer Database.
Hayek SA; Munoz A; Dove JT; Hunsinger M; Arora T; Wild J; Shabahang M; Blansfield J
Am Surg; 2018 May; 84(5):672-679. PubMed ID: 29966567
[TBL] [Abstract][Full Text] [Related]
3. Should Sentinel Lymph Node Biopsy Be Performed for All T1b Melanomas in the New 8
Egger ME; Stevenson M; Bhutiani N; Jordan AC; Scoggins CR; Philips P; Martin RC; McMasters KM
J Am Coll Surg; 2019 Apr; 228(4):466-472. PubMed ID: 30660817
[TBL] [Abstract][Full Text] [Related]
4. Sentinel lymph node biopsy guideline concordance in melanoma: Analysis of the National Cancer Database.
Narang J; Hue JJ; Bingmer K; Hardacre JM; Winter JM; Ocuin LM; Ammori JB; Mangla A; Bordeaux J; Rothermel LD
J Surg Oncol; 2021 Sep; 124(4):669-678. PubMed ID: 34109633
[TBL] [Abstract][Full Text] [Related]
5. Impact of National Comprehensive Cancer Network Guidelines on Case Selection and Outcomes for Sentinel Lymph Node Biopsy in Thin Melanoma.
Nguyen B; Karia PS; Hills VM; Besaw RJ; Schmults CD
Dermatol Surg; 2018 Apr; 44(4):493-501. PubMed ID: 29059142
[TBL] [Abstract][Full Text] [Related]
6. Practice variation in Sentinel Lymph Node Biopsy for melanoma patients in different geographical regions in the Netherlands.
Verstijnen J; Damude S; Hoekstra HJ; Kruijff S; Ten Tije AJ; Louwman WJ; Bastiaannet E; Stuiver MM
Surg Oncol; 2017 Dec; 26(4):431-437. PubMed ID: 29113662
[TBL] [Abstract][Full Text] [Related]
7. Compliance with sentinel lymph node biopsy guidelines for invasive melanomas treated with Mohs micrographic surgery.
MacArthur KM; Baumann BC; Sobanko JF; Etzkorn JR; Shin TM; Higgins HW; Giordano CN; McMurray SL; Krausz A; Newman JG; Rajasekaran K; Cannady SB; Brody RM; Karakousis GC; Miura JT; Cohen JV; Amaravadi RK; Mitchell TC; Schuchter LM; Miller CJ
Cancer; 2021 Oct; 127(19):3591-3598. PubMed ID: 34292585
[TBL] [Abstract][Full Text] [Related]
8. Trends in Sentinel Lymph Node Biopsy Enactment for Cutaneous Melanoma.
El Sharouni MA; Witkamp AJ; Sigurdsson V; van Diest PJ
Ann Surg Oncol; 2019 May; 26(5):1494-1502. PubMed ID: 30719636
[TBL] [Abstract][Full Text] [Related]
9. Sentinel Lymph Node Biopsy Provides Prognostic Value in Thick Head and Neck Melanoma.
Monroe MM; Pattisapu P; Myers JN; Kupferman ME
Otolaryngol Head Neck Surg; 2015 Sep; 153(3):372-8. PubMed ID: 26070510
[TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node biopsy is accurate and prognostic in head and neck melanoma.
Erman AB; Collar RM; Griffith KA; Lowe L; Sabel MS; Bichakjian CK; Wong SL; McLean SA; Rees RS; Johnson TM; Bradford CR
Cancer; 2012 Feb; 118(4):1040-7. PubMed ID: 21773971
[TBL] [Abstract][Full Text] [Related]
11. Primary excision margins, sentinel lymph node biopsy, and completion lymph node dissection in cutaneous melanoma: a clinical practice guideline.
Wright FC; Souter LH; Kellett S; Easson A; Murray C; Toye J; McCready D; Nessim C; Ghazarian D; Hong NJL; Johnson S; Goldstein DP; Petrella T;
Curr Oncol; 2019 Aug; 26(4):e541-e550. PubMed ID: 31548823
[TBL] [Abstract][Full Text] [Related]
12. Melanoma of the ear: prognostic factors and surgical strategies.
Jahn V; Breuninger H; Garbe C; Moehrle M
Br J Dermatol; 2006 Feb; 154(2):310-8. PubMed ID: 16433802
[TBL] [Abstract][Full Text] [Related]
13. Treatment and outcomes of melanoma with a Breslow's depth greater than or equal to one millimeter in a regional teaching hospital.
Scott JD; McKinley BP; Bishop A; Trocha SD
Am Surg; 2005 Mar; 71(3):198-201. PubMed ID: 15869131
[TBL] [Abstract][Full Text] [Related]
14. Incidence and location of positive nonsentinel lymph nodes in head and neck melanoma.
Gyorki DE; Boyle JO; Ganly I; Morris L; Shaha AR; Singh B; Wong RJ; Shah JP; Busam K; Kraus D; Coit DG; Patel S
Eur J Surg Oncol; 2014 Mar; 40(3):305-10. PubMed ID: 24361245
[TBL] [Abstract][Full Text] [Related]
15. Population-based assessment of surgical treatment trends for patients with melanoma in the era of sentinel lymph node biopsy.
Cormier JN; Xing Y; Ding M; Lee JE; Mansfield PF; Gershenwald JE; Ross MI; Du XL
J Clin Oncol; 2005 Sep; 23(25):6054-62. PubMed ID: 16135473
[TBL] [Abstract][Full Text] [Related]
16. Management of regional lymph nodes in the elderly melanoma patient: patient selection, accuracy and prognostic implications.
Grotz TE; Puig CA; Perkins S; Ballman K; Hieken TJ
Eur J Surg Oncol; 2015 Jan; 41(1):157-64. PubMed ID: 25468751
[TBL] [Abstract][Full Text] [Related]
17. A retrospective, multicenter analysis of the predictive value of mitotic rate for sentinel lymph node (SLN) positivity in thin melanomas.
Wat H; Senthilselvan A; Salopek TG
J Am Acad Dermatol; 2016 Jan; 74(1):94-101. PubMed ID: 26542815
[TBL] [Abstract][Full Text] [Related]
18. A population-based assessment of melanoma: Does treatment in a regional cancer center make a difference?
Rivard J; Kostaras X; Shea-Budgell M; Chin-Lenn L; Quan ML; McKinnon JG
J Surg Oncol; 2015 Aug; 112(2):173-8. PubMed ID: 26445222
[TBL] [Abstract][Full Text] [Related]
19. Compliance with guidelines in the surgical management of cutaneous melanoma across the USA.
Wasif N; Gray RJ; Bagaria SP; Pockaj BA
Melanoma Res; 2013 Aug; 23(4):276-82. PubMed ID: 23695440
[TBL] [Abstract][Full Text] [Related]
20. Melanoma nodal management in Ontario the year after the 2012 American Society of Clinical Oncology and Society of Surgical Oncology guideline.
Latosinsky S; Allen B; Shariff SZ
Curr Oncol; 2019 Oct; 26(5):330-337. PubMed ID: 31708651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
